BridgeBio Pharma, Inc. (BBIO) is listed on NASDAQ in Pharmaceutical Stocks. It is $76.62, -2.62%, with a $15.0B market cap. RSI is 35.2, near oversold. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 35.2 Near Oversold
Market Cap $15.0B
Volume 2.0M
Fundamentals — 10-Q Q2 2026
Revenue $438.2M
Net Income --
EPS $-1.62
Gross Margin 94.3%
Operating Margin -48.6%
Debt / Equity -1.1x
P/E Ratio -47.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Kumar Neil | Chief Executive Officer | Sell | 44,980 | $82.86 | $3.7M | 2026 Aug 19 |
| Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $80.06 | $160,120 | 2026 Jul 30 |
| Ellis Andrea | Director | Sell | 17,167 | $84.00 | $1.4M | 2026 Jul 9 |
| Cook Jennifer E. | Director | Sell | 148,589 | $88.54 | $13.2M | 2026 Jul 9 |
| Cook Jennifer E. | Director | Sell | 39,363 | $69.92 | $2.8M | 2026 Jun 24 |
| Valantine Hannah | Director | Sell | 5,004 | $68.25 | $341,524 | 2026 Jun 23 |
| Cook Jennifer E. | Director | Sell | 90,240 | $66.62 | $6.0M | 2026 Jun 15 |
| Kumar Neil | Chief Executive Officer | Sell | 80,000 | $67.67 | $5.4M | 2026 Jun 5 |
| Kumar Neil | Chief Executive Officer | Sell | 26,103 | $69.44 | $1.8M | 2026 May 21 |
| Trimarchi Thomas | President and CFO | Sell | 13,651 | $65.08 | $888,419 | 2026 May 18 |
| Scott Randal W. | Director | Sell | 10,000 | $67.15 | $671,456 | 2026 May 15 |
| Kumar Neil | Chief Executive Officer | Sell | 80,000 | $67.40 | $5.4M | 2026 May 8 |
| Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $71.58 | $143,160 | 2026 Apr 30 |
| Kumar Neil | Chief Executive Officer | Sell | 80,000 | $74.61 | $6.0M | 2026 Apr 10 |
| Kumar Neil | Chief Executive Officer | Sell | 80,000 | $68.76 | $5.5M | 2026 Mar 13 |
| Valantine Hannah | Director | Sell | 8,671 | $72.00 | $624,312 | 2026 Mar 10 |
| Ellis Andrea | Director | Sell | 64,921 | $64.87 | $4.2M | 2026 Mar 4 |
| Valantine Hannah | Director | Sell | 25,484 | $67.41 | $1.7M | 2026 Feb 27 |
| Apuli Maricel | Chief Accounting Officer | Sell | 2,000 | $66.00 | $132,000 | 2026 Feb 26 |
| Kumar Neil | Chief Executive Officer | Sell | 28,053 | $71.39 | $2.0M | 2026 Feb 19 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $18.03 | 47.2 | $6.3B |
| | $72.17 | 37.1 | $10.0B |
| | $113.77 | 55.4 | $12.3B |
| | $64.65 | 51.0 | $12.5B |
| | $84.95 | 54.8 | $12.0B |
Take BBIO further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BBIO in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when BridgeBio Pharma, Inc. next reports.
Set alerts on BBIO
Get notified when BridgeBio Pharma, Inc. hits your price targets or technical conditions are met.
Get Started Free